• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Episurf Medical

0,11 SEK

-1,29 %

Mindre end 1K følgere

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
-1,29 %
+48,34 %
+116,97 %
+189,49 %
+282,21 %
+43,84 %
-83,36 %
-93,98 %
-97,03 %

Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The company aims to create value growth through the acquisition and management of Nordic properties. The company also has a medical technology business based on the personalized implant Episealer® and associated surgical instruments, which are used to treat cartilage damage in joints. Episurf Medical's headquarters are located in Stockholm, Sweden.

Læs mere
Markedsværdi
654,83 mio. SEK
Aktieomsætning
2,55 mio. SEK
Omsætning
13,5 mio.
EBIT %
-428,89 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
EPS og udbytte
Finanskalender
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
24.8
2026

Delårsrapport Q2'26

13.11
2026

Delårsrapport Q3'26

5.2
2027

Årsrapport '26

Selskabsmeddelelse5.6.2026, 14.30

Episurf Medical acquires a mixed property portfolio of 30 properties in Södermanland and Östergötland with an agreed property value of SEK 920 mn from Livi Fastigheter AB

Episurf Medical
Selskabsmeddelelse4.6.2026, 17.30

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertibles and warrants as part of the consideration for the acquisition of property assets

Episurf Medical
Selskabsmeddelelse29.5.2026, 13.44

Episurf Medical acquires a portfolio of four properties in Uppsala with an agreed property value of SEK 300 mn from Setune

Episurf Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse26.5.2026, 10.00

Episurf Medical acquires properties in Borås

Episurf Medical
Selskabsmeddelelse25.5.2026, 14.26

Bulletin from Annual General Meeting in Episurf Medical AB (publ)

Episurf Medical
Selskabsmeddelelse25.5.2026, 08.32

Correction: Missing MAR label in previous press release - Interim Report 1 January - 31 March 2026

Episurf Medical
Selskabsmeddelelse25.5.2026, 05.00

Interim Report 1 January - 31 March 2026

Episurf Medical
Selskabsmeddelelse22.5.2026, 05.30

Episurf Medical acquires a real estate portfolio with an agreed property value of SEK 660m from Lilium

Episurf Medical
Pressemeddelelse21.5.2026, 11.26

Episurf Medical strengthens its organisation with a Deputy CEO, Christian Oloffson, and Head of Property Management, Petra Widén Lindh

Episurf Medical
Selskabsmeddelelse11.5.2026, 14.00

Episurf Medical acquires property portfolio with an agreed property value of SEK 845 mn from Botrygg

Episurf Medical
Selskabsmeddelelse5.5.2026, 06.41

Episurf Medical has entered into letters of intent to acquire four real estate portfolios with a combined agreed property value of approximately SEK 2.6 billion

Episurf Medical
Selskabsmeddelelse30.4.2026, 09.45

Change in number of shares and votes in Episurf Medical

Episurf Medical
Selskabsmeddelelse23.4.2026, 15.40

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of the consideration for the acquisition of real estate assets

Episurf Medical
Selskabsmeddelelse21.4.2026, 06.00

Notice convening the Annual General Meeting of Episurf Medical AB (publ)

Episurf Medical
Selskabsmeddelelse20.4.2026, 09.00

Episurf Medical initiates dual-track process for its medtech operations

Episurf Medical
Selskabsmeddelelse17.4.2026, 14.45

The Board of Directors of Episurf has resolved on an issue of Class B shares and warrants as part of the consideration for the acquisition of real estate assets

Episurf Medical
Pressemeddelelse13.4.2026, 14.00

Press release from extraordinary general meeting in Episurf Medical AB (publ)

Episurf Medical
Selskabsmeddelelse2.4.2026, 10.15

Episurf Medical Acquires Property Portfolio with an Agreed Property Value of SEK 697 Million from Mofast AB

Episurf Medical
Selskabsmeddelelse20.3.2026, 16.30

Episurf Medical AB's 2025 annual report is now available

Episurf Medical
Selskabsmeddelelse11.3.2026, 07.30

Notice of Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical